CURRENT METHODS FOR SITE-DIRECTED STRUCTURE GENERATION

被引:50
作者
LEWIS, RA [1 ]
LEACH, AR [1 ]
机构
[1] UNIV SOUTHAMPTON,DEPT CHEM,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND
关键词
DRUG DESIGN; DE NOVO DESIGN; PROTEIN-LIGAND COMPLEXES; ENZYME INHIBITORS;
D O I
10.1007/BF00125381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There has been a rapid growth of interest in techniques for site-directed drug design, fuelled by the increasing availability of structural models of proteins of therapeutic importance, and by studies reported in the literature showing that potent chemical leads can be obtained by these techniques. Structure generation programs offer the prospect of discovering highly original lead structures from novel chemical families. Due to the fact that this technique is more-or-less still in its infancy, there are no case studies available that demonstrate the use of structure generation programs for site-directed drug design. Such programs were first proposed in 1986, and became commercially available in early 1992. They have shown their ability to reproduce, or suggest reasonable alternatives for, ligands in well-defined binding sites. This brief review will discuss the recent advances that have been made in the field of site-directed structure generation.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 42 条
  • [1] CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTER - COMPUTER-BASED SEARCH, RETRIEVAL, ANALYSIS AND DISPLAY OF INFORMATION
    ALLEN, FH
    BELLARD, S
    BRICE, MD
    CARTWRIGHT, BA
    DOUBLEDAY, A
    HIGGS, H
    HUMMELINK, T
    HUMMELINKPETERS, BG
    KENNARD, O
    MOTHERWELL, WDS
    RODGERS, JR
    WATSON, DG
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (OCT): : 2331 - 2339
  • [2] DESIGN OF ENZYME-INHIBITORS USING ITERATIVE PROTEIN CRYSTALLOGRAPHIC ANALYSIS
    APPELT, K
    BACQUET, RJ
    BARTLETT, CA
    BOOTH, CLJ
    FREER, ST
    FUHRY, MAM
    GEHRING, MR
    HERRMANN, SM
    HOWLAND, EF
    JANSON, CA
    JONES, TR
    KAN, CC
    KATHARDEKAR, V
    LEWIS, KK
    MARZONI, GP
    MATTHEWS, DA
    MOHR, C
    MOOMAW, EW
    MORSE, CA
    OATLEY, SJ
    OGDEN, RC
    REDDY, MR
    REICH, SH
    SCHOETTLIN, WS
    SMITH, WW
    VARNEY, MD
    VILLAFRANCA, JE
    WARD, RW
    WEBBER, S
    WEBBER, SE
    WELSH, KM
    WHITE, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (07) : 1925 - 1934
  • [3] BOHACEK R, 1992, 12TH INT S MED CHEM
  • [4] LUDI - RULE-BASED AUTOMATIC DESIGN OF NEW SUBSTITUENTS FOR ENZYME-INHIBITOR LEADS
    BOHM, HJ
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (06) : 593 - 606
  • [5] THE COMPUTER-PROGRAM LUDI - A NEW METHOD FOR THE DENOVO DESIGN OF ENZYME-INHIBITORS
    BOHM, HJ
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (01) : 61 - 78
  • [6] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [7] CHAIN CLOSURE WITH BOND ANGLE VARIATIONS
    BRUCCOLERI, RE
    KARPLUS, M
    [J]. MACROMOLECULES, 1985, 18 (12) : 2767 - 2773
  • [8] AUTOMATED SITE-DIRECTED DRUG DESIGN - THE PREDICTION AND OBSERVATION OF LIGAND POINT POSITIONS AT HYDROGEN-BONDING REGIONS ON PROTEIN SURFACES
    DANZIGER, DJ
    DEAN, PM
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1989, 236 (1283): : 115 - +
  • [9] DEAN PM, 1987, MOL F DRUG RECEPTOR
  • [10] DOCKING FLEXIBLE LIGANDS TO MACROMOLECULAR RECEPTORS BY MOLECULAR SHAPE
    DESJARLAIS, RL
    SHERIDAN, RP
    DIXON, JS
    KUNTZ, ID
    VENKATARAGHAVAN, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (11) : 2149 - 2153